Cargando…
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
Visceral leishmaniasis (VL) is a serious parasitic disease causing considerable mortality and major disability in the Indian subcontinent. It is most neglected tropical disease, particularly in terms of new drug development for the lack of financial returns. An elimination campaign has been running...
Autores principales: | Singh, Om Prakash, Singh, Bhawana, Chakravarty, Jaya, Sundar, Shyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782357/ https://www.ncbi.nlm.nih.gov/pubmed/26951132 http://dx.doi.org/10.1186/s40249-016-0112-2 |
Ejemplares similares
-
Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019) -
Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014) -
Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014) -
Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015) -
Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)